CID 162368377

Eltrombopag metabolite g

Structural Information

Molecular Formula
C28H27N5O6S
SMILES
CC1=C(C=CC(=C1)N2C(=O)C(=C(N2)C)N=NC3=CC=CC(=C3O)C4=CC(=CC=C4)C(=O)O)CSCC(C(=O)O)N
InChI
InChI=1S/C28H27N5O6S/c1-15-11-20(10-9-19(15)13-40-14-22(29)28(38)39)33-26(35)24(16(2)32-33)31-30-23-8-4-7-21(25(23)34)17-5-3-6-18(12-17)27(36)37/h3-12,22,32,34H,13-14,29H2,1-2H3,(H,36,37)(H,38,39)
InChIKey
WQZANSUNXCWHJM-UHFFFAOYSA-N
Compound name
3-[3-[[2-[4-[(2-amino-2-carboxyethyl)sulfanylmethyl]-3-methylphenyl]-5-methyl-3-oxo-1H-pyrazol-4-yl]diazenyl]-2-hydroxyphenyl]benzoic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

0
Patents

561.1682 Da
Monoisotopic Mass

1.9
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 562.17548 233.1
[M+Na]+ 584.15742 242.4
[M+NH4]+ 579.20202 234.6
[M+K]+ 600.13136 238.8
[M-H]- 560.16092 237.6
[M+Na-2H]- 582.14287 238.3
[M]+ 561.16765 235.5
[M]- 561.16875 235.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.